Menu
 
» » » FOX NEWS: Gilead Phase III trial of remdesivir for COVID-19 shows 65 percent are 'more likely' to improve by day 11

A+ A-
Unknown Unknown Author
Title: FOX NEWS: Gilead Phase III trial of remdesivir for COVID-19 shows 65 percent are 'more likely' to improve by day 11
Author: Unknown
Rating 5 of 5 Des:
Gilead Phase III trial of remdesivir for COVID-19 shows 65 percent are 'more likely' to improve by day 11 Gilead Sciences said ...

Gilead Phase III trial of remdesivir for COVID-19 shows 65 percent are 'more likely' to improve by day 11



Gilead Sciences said on Monday that remdesivir, the experimental drug being tested for COVID-19, showed that 65 percent of moderately ill patients had improvement after 11 days.

via FOX NEWS https://ift.tt/2MmAjbm
Labels: ,

Share to:

at June 01, 2020

Advertisement

Post a Comment

Subscribe to: Post Comments (Atom)
 
Top